NSCLC, metastatic CheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC
Socinski, M., Creelan, B., Horn, L., Reck, M., Paz-Ares, L., Steins, M., Felip, E., van den Heuvel, M., Ciuleanu, T.E., Badin, F., Ready, N., Hiltermann, T.J.N., Nair, S., Juergens, R., Peters, S., Minenza, E., Geese, W.J., Bhagavatheeswaran, P., Chen, A., Carbone, D.P.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
9001 ORAL A Retrospective Subgroup Analysis of EGFR Immunohistochemistry (IHC) Expression by Histo-Score Correlated to Outcomes From the BMS099 1st Line Phase III NSCLC Trial of Cetuximab (Cet) Plus Carboplatin/Taxane
Lynch, T, Bhagavatheeswaran, P, Mukhopadhyay, P, Khambata-Ford, S, Harbison, C.T
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer
Hellmann, Matthew D, Paz-Ares, Luis, Bernabe Caro, Reyes, Zurawski, Bogdan, Kim, Sang-We, Carcereny Costa, Enric, Park, Keunchil, Alexandru, Aurelia, Lupinacci, Lorena, de la Mora Jimenez, Emmanuel, Sakai, Hiroshi, Albert, Istvan, Vergnenegre, Alain, Peters, Solange, Syrigos, Konstantinos, Barlesi, Fabrice, Reck, Martin, Borghaei, Hossein, Brahmer, Julie R, O’Byrne, Kenneth J, Geese, William J, Bhagavatheeswaran, Prabhu, Rabindran, Sridhar K, Kasinathan, Ravi S, Nathan, Faith E, Ramalingam, Suresh S
Published in The New England journal of medicine (21.11.2019)
Published in The New England journal of medicine (21.11.2019)
Get full text
Journal Article
Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden
Hellmann, Matthew D, Ciuleanu, Tudor-Eliade, Pluzanski, Adam, Lee, Jong Seok, Otterson, Gregory A, Audigier-Valette, Clarisse, Minenza, Elisa, Linardou, Helena, Burgers, Sjaak, Salman, Pamela, Borghaei, Hossein, Ramalingam, Suresh S, Brahmer, Julie, Reck, Martin, O’Byrne, Kenneth J, Geese, William J, Green, George, Chang, Han, Szustakowski, Joseph, Bhagavatheeswaran, Prabhu, Healey, Diane, Fu, Yali, Nathan, Faith, Paz-Ares, Luis
Published in The New England journal of medicine (31.05.2018)
Published in The New England journal of medicine (31.05.2018)
Get full text
Journal Article
75TiP A multicenter, open-label, phase II trial evaluating the safety and efficacy of folate receptor alpha (FRα) antibody-drug conjugate (ADC) farletuzumab ecteribulin (FZEC) in patients with previously treated, metastatic non-small cell lung cancer (NSCLC) adenocarcinoma (AC)
Planchard, D., Paz-Ares, L., Spira, A., Felip, E., McCune, S., Cascella, T., Dennie, J., Bhagavatheeswaran, P., Dumitru, C., Borghaei, H.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
LBA3 Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (aNSCLC): CheckMate 227 - part 2 final analysis
Paz-Ares, L., Ciuleanu, T.E., Yu, X., Salman, P., Pluzanski, A., Nagrial, A., Havel, L., Kowalyszyn, R., Audigier-Valette, C., Wu, Y.-L., Borghaei, H., Hellmann, M.D., Brahmer, J., Reck, M., Ramalingam, S., Zhang, L., Bhagavatheeswaran, P., Nathan, F.E., O'Byrne, K.J.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
PS2 CheckMate 227: Nivolumab + Ipilimumab vs Chemotherapy as 1L Treatment for Advanced NSCLC With High Tumor Mutational Burden
Mathias, C., Reck, M., Hellmann, M., Ramalingam, S., Brahmer, J., O'Byrne, K., Bhagavatheeswaran, P., Nathan, F., Borghaei, H., Paz-Ares, L.
Published in Journal of thoracic oncology (01.09.2018)
Published in Journal of thoracic oncology (01.09.2018)
Get full text
Journal Article
LBA4_PRNivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis
Peters, S, Ramalingam, S S, Paz-Ares, L, Bernabe Caro, R, Zurawski, B, Kim, S-W, Alexandru, A, Lupinacci, L, de la Mora Jimenez, E, Sakai, H, Albert, I, Vergnenegre, A, Reck, M, Borghaei, H, Brahmer, J R, O’Byrne, K J, Geese, W J, Bhagavatheeswaran, P, Nathan, F E, Hellmann, M D
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA4_PR - Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis
Peters, S., Ramalingam, S.S., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.-W., Alexandru, A., Lupinacci, L., de la Mora Jimenez, E., Sakai, H., Albert, I., Vergnenegre, A., Reck, M., Borghaei, H., Brahmer, J.R., O’Byrne, K.J., Geese, W.J., Bhagavatheeswaran, P., Nathan, F.E., Hellmann, M.D.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis
Peters, S., Ramalingam, S.S., Paz-Ares, L., Bernabe Caro, R., Zurawski, B., Kim, S.-W., Alexandru, A., Lupinacci, L., de la Mora Jimenez, E., Sakai, H., Albert, I., Vergnenegre, A., Reck, M., Borghaei, H., Brahmer, J.R., O’Byrne, K.J., Geese, W.J., Bhagavatheeswaran, P., Nathan, F.E., Hellmann, M.D.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
OA05.06 CheckMate 227: Patient-Reported Outcomes of First-Line Nivolumab + Ipilimumab in High Tumor Mutational Burden Advanced NSCLC
Brahmer, J., Schenker, M., Lee, K.H., Provencio, M., Nishio, M., Lesniewski-Kmak, K., Sangha, R., Ahmed, S., Raimbourg, J., Feeney, K., Corre, R., Franke, F., Richardet, E., Penrod, J., Yuan, Y., Nathan, F., Bhagavatheeswaran, P., De Rosa, M., Taylor, F., Lawrance, R., Reck, M.
Published in Journal of thoracic oncology (01.10.2018)
Published in Journal of thoracic oncology (01.10.2018)
Get full text
Journal Article
CheckMate 227 : nivolumab (nivo) + ipilimumab (ipi) versus doublet de chimiothérapie à base de sels de platine (chimio) en traitement de première ligne (1L) du cancer bronchique non à petites cellules (CBNPC) avancé avec une charge mutationnelle tumorale (Tumor Mutational Burden, TMB) élevée
Audigier-Valette, C., Reck, M., Hellmann, M.D., Paz-Ares, L., Ramalingam, S.S., Brahmer, J., Bhagavatheeswaran, P., Nathan, F., Borghaei, H., O’byrne, K.J.
Published in Revue des maladies respiratoires (01.01.2019)
Published in Revue des maladies respiratoires (01.01.2019)
Get full text
Journal Article